Skip to main content

Allgemeine Grundlagen der Pharmakokinetik und Pharmakodynamik

  • Chapter
Neuro-Psychopharmaka
  • 78 Accesses

Zusammenfassung

Dieses Kapitel über Pharmakokinetik sollte nur als Einführung in ein Gebiet angesehen werden, das in anderen, sich ausschliesslich mit diesem Bereich beschäftigenden Werken umfassender beschrieben wurde (Tozer 1981, Rowland und Tozer 1989, Gilman et al. 1990, Klotz 1983). Es behandelt die quantitativen Beziehungen, die zwischen der Verabreichung eines Medikamentes und seiner klinischen Wirkung bestehen. Die hier dargestellten Beispiele dienen nur zur Illustration, da die Kinetik und Dynamik einzelner Pharmakagruppen in den jeweiligen Kapiteln eingehend beschrieben werden. Die zwei folgenden Begriffe verlangen eine genaue Definition: Die Pharmakokinetik befaßt sich mit den Zusammenhängen zwischen der Medikamentendosis, seiner Verabreichungsart und den Konzentrationen der aktiven Komponente am Wirkungsort oder Rezeptor. Da diese in den meisten Fällen nicht meßbar sind, werden sie vereinfachend den Konzentrationen des freien, nicht an Eiweiße gebundenen Wirkstoffes im Plasma gleichgesetzt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amdisen A (1983) Serum level monitoring and clinical pharmacokinetics of lithium. In: Gibaldi M, Prescott L (eds) Handbook of clinical pharmacokinetics. Section IV. Therapeutic drug monitoring and dosage prediction. ADIS Health Science Press, New York Tokyo Mexico Sydney Auckland Hong Kong, pp 109–131.

    Google Scholar 

  • Amdisen A, Nielsen-Kudsk (1986) Relationship between standardized twelve-hour serum lithium, mean serum lithium of the 24-hour day, dose regimen, and therapeutic interval. An evaluation based on pharmacokinetic simulations. Pharmacopsychiatry 19: 416–419.

    Article  PubMed  CAS  Google Scholar 

  • American College of Clinical Pharmacology: Allen L, Kimura K, MacKichan J, Ritschel WA, Ad hoc committee for pharmacokinetic nomenclature (1982) In: Manual of symbols, equations & definitions in pharmacokinetics. Philadelphia. Am Coll Clin Pharmacol, pp 1-19.

    Google Scholar 

  • Balant-Gorgia AE, Balant L (1987) Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring. Clin Pharmacokinet 13: 65–90.

    Article  PubMed  CAS  Google Scholar 

  • Baumann P, Tinguely D, Koeb L, Schöpf J, Le PK (1982) On the relationship between free plasma and saliva amitriptyline and nortriptyline. Int Pharmacopsychiatry 17: 136–146.

    PubMed  CAS  Google Scholar 

  • Baumann P, Eap CB, Müller WE, Tillement JP (eds) (1989) Alphal-acid glycoprotein. Genetics, biochemistry, physiological functions, and pharmacology. Alan R Liss, New York, p 470.

    Google Scholar 

  • Bertschy G, Vandel S, Vandel B, Allers G, Bechtel P, Volmat R (1989) Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity. Pharmacopsychiatry 22: 161–164.

    Article  PubMed  CAS  Google Scholar 

  • Breyer-Pfaff U, Gaertner HJ (1987) Antidepressiva. Pharmakologie, therapeutischer Einsatz und Klinik der Depression. Medizinisch-pharmakologisches Kompendium, Bd 5. Wissenschaftl Verlagsgesellschaft mbH, Stuttgart, S 252.

    Google Scholar 

  • Browne JL, Perry PJ, Alexander B, Sherman AD, Tsuang MT, Dunner F, Pfohl B (1983) Pharmacokinetic protocol for predicting plasma nortriptyline levels. J Clin Psychopharmacol 3: 351–356.

    Article  PubMed  CAS  Google Scholar 

  • Burchell B, Coughtrie MWH (1989) UDP-Glucuronosyltransferases. Pharmacol Ther 43: 261–289.

    Article  PubMed  CAS  Google Scholar 

  • Campbell DB (1990) The use of kinetic-dynamic interactions in the evaluation of drugs. Psychopharmacology 100: 433–450.

    Article  PubMed  CAS  Google Scholar 

  • Crismon ML (1983) Benzodiazepine anxiolytics. In: Mungall DR (ed) Applied clinical pharmacokinetics. Raven Press, New York, pp 285–302.

    Google Scholar 

  • Dahl SG (1986) Plasma level monitoring of antipsychotic drugs. Clinical utility. Clin Pharmacokinet 11: 36–61.

    Article  PubMed  CAS  Google Scholar 

  • Dawling S, Braithwaite R, McAuley R, Montgomery S (1980) Single oral dose pharmacokinetics of amitriptyline and maprotiline in depressed patients. Prediction of steady-state plasma concentrations. In: Beaumont G, Purcell H, Williams NJ (eds) British Journal of Clinical Practice 1980 Symposium (Ciba) Jersey, 79; Supplement 7. New Perspectives in Depressive Illness. Cradley Heath, Cradley Printing.

    Google Scholar 

  • Dobbs JH (1983) The tricyclic antidepressants. In: Mungall DR (ed) Applied clinical pharmacokinetics. Raven Press, New York, pp 271–284.

    Google Scholar 

  • Geller B, Cooper TB, Chestnut EC, Anker JA, Price DT, Yates E (1985) Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data. J Clin Psychopharmacol 5: 154–158.

    PubMed  CAS  Google Scholar 

  • Gilman AG, Rall TW, Nies AS, Taylor P (1990) Goodman and Gilman’s: the pharmacological basis of therapeutics. Pergamon Press, New York.

    Google Scholar 

  • Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI (1983) Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 8: 233–252.

    Article  PubMed  CAS  Google Scholar 

  • Guentert TW (1984) Pharmacokinetics of benzodiazepines and of their metabolites. Prog Drug Metabol 8: 241–386.

    CAS  Google Scholar 

  • Holford NHG, Sheiner LB (1981) Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6: 429–453.

    Article  PubMed  CAS  Google Scholar 

  • Jørgensen A (1986) Metabolism and pharmacokinetics of antipsychotic drugs. Prog Drug Metabol 9: 111–174.

    Google Scholar 

  • Klotz U (1983) Individualisierung der Medikamentendosierung durch Arzneimittelmessungen im Plasma und Anwendung pharmakokinetischer Prinzipien. J Clin Chem Clin Biochem 21: 649–658.

    PubMed  CAS  Google Scholar 

  • Levy RH, Moreland TA (1984) Rationale for monitoring free drug levels. Clin Pharmacokinet 9[Suppl 1]: 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Madakasira S, Khazanie PG, Sato TL (1984) Single dose single-point method in amitriptyline therapy. Psychopharmacology 84: 574–576.

    Article  PubMed  CAS  Google Scholar 

  • Mucklow JC, Bending MR, Kahn GC, Dollery CT (1978) Drug concentration in saliva. Clin Pharmacol Ther 24: 563–570.

    PubMed  CAS  Google Scholar 

  • Nelson JC, Jatlow PI, Mazure C (1987) Rapid desipramine dose adjustment using 24-hour levels. J Clin Psychopharmacol 7: 72–77.

    PubMed  CAS  Google Scholar 

  • Oosterhuis B, van Boxtel CJ (1988) Kinetics of drug effects in man. Ther Drug Monit 10: 121–132.

    Article  PubMed  CAS  Google Scholar 

  • Paxton JW (1979) Measurement of drugs in saliva: a review. Methods Find Exp Clin Pharmacol 1: 11–21.

    PubMed  CAS  Google Scholar 

  • Piafsky KM (1983) Disease-induced changes in the plasma binding of basic drugs. In: Gibaldi M, Prescott L (eds) Handbook of clinical pharmacokinetics. Section III. Effect of disease states on drug disposition. ADIS Health Science Press, New York Tokyo Mexico Sydney Auckland Hong Kong, pp 70–88.

    Google Scholar 

  • Preskorn SH (1989) Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. J Clin Psychiatry 50[Suppl 7]: 34–42.

    PubMed  Google Scholar 

  • Reyntjens AJM, Heykants JJP, Woestenborghs RJH, Gelders YG, Aerts TJL (1982) Pharmacokinetics of haloperidol decanoate. A two-year follow-up. Int Pharmacopsychiatr 17: 238–246.

    Google Scholar 

  • Richens A, Marks V (eds) (1981) Therapeutic drug monitoring, 1st ed. Churchill Livingstone, London.

    Google Scholar 

  • Rosenberg JG, Binder RL, Berlant J (1987) Prediction of therapeutic lithium dose: comparison and improvement of current methods. J Clin Psychiatry 48: 284–286.

    PubMed  CAS  Google Scholar 

  • Rowland M, Tozer TN (eds) (1989) Clinical pharmacokinetics: concepts and applications. Lea & Febiger, Philadelphia, p 331.

    Google Scholar 

  • Schumacher GE, Barr JT (1984) Bayesian approaches in pharmacokinetic decision making. Clin Pharm 3: 525–530.

    PubMed  CAS  Google Scholar 

  • Sindrup SH, Brosen K, Gram LF (1990) Nonlinear kinetics of imipramine in low and medium plasma level ranges. Ther Drug Monit 12: 445–449.

    Article  PubMed  CAS  Google Scholar 

  • Tillement JP, Houin G, Zini R, Urien S, Albengres E, Barre J, Lecomte M, D’Athis P, Sebille B (1984) The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance. Adv Drug Res 13: 59–94.

    CAS  Google Scholar 

  • Tillement JP, Lindenlaub E (eds) (1985) Protein binding and drug transport. Symposium Alvor, Algarve, Portugal, Sept. 85. Symposia Medica Hoechst 20. Schattauer, Stuttgart New York, p 530.

    Google Scholar 

  • Tozer TN (1981) Concepts basic to pharmacokinetics. Pharmacol Ther 12: 109–131.

    Article  PubMed  CAS  Google Scholar 

  • Wandell M, Wilcox-Thole WL (1983) Protein binding and free drug concentration. In: Mungall DR (ed) Applied clinical pharmacokinetics. Raven Press, New York, pp 17–48.

    Google Scholar 

  • Williams PJ, Browne JL, Patel RA (1989) Bayesian forecasting of serum lithium concentrations. Comparison with traditional methods. Clin Pharmacokinet 17: 45–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Wien

About this chapter

Cite this chapter

Buclin, T., Baumann, P. (1992). Allgemeine Grundlagen der Pharmakokinetik und Pharmakodynamik. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6674-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6674-1_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7377-0

  • Online ISBN: 978-3-7091-6674-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics